XML 65 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1

Note 15 - Stock Option Plans (Tables)

12 Months Ended

Dec. 31, 2024

Notes Tables

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

		Year Ended December 31,
		2024				2023				2022
Volatility			48.4	%			42.6	%			34.9	%
Risk-free interest rate			4.2	%			4.2	%			3.4	%
Expected life (in years)			4.45				4.46				4.60
Dividend yield			0.0	%			0.0	%			0.0	%
The weighted average grant date fair value for options issued, with the exercise price equal to market value on the date of grant		$	9.61			$	10.34			$	14.93

		Year Ended December 31,
		2024				2023				2022
Volatility			42.7	%			40.6	%			40.7	%
Risk-free interest rate			4.6	%			4.3	%			4.4	%
Expected life (in years)			4.38				4.17				4.16
Dividend yield			0.0	%			0.0	%			0.0	%
The weighted average grant date fair value for options issued, with the exercise price equal to market value on the date of grant		$	0.52			$	0.49			$	0.49

		Year Ended December 31,
		2024				2023				2022
Volatility			36.3	%			35.8	%			N/A
Risk-free interest rate			3.8	%			3.8	%			N/A
Expected life (in years)			4.36				4.18				N/A
Dividend yield			0.0	%			0.0	%			N/A
The weighted average grant date fair value for options issued, with the exercise price equal to market value on the date of grant		$	0.13			$	0.11				N/A

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Year Ended December 31, 2024								Year Ended December 31, 2023								Year Ended December 31, 2022
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,132,632			$	54.61				1,036,748			$	59.97				904,151			$	64.36
Granted			323,358				21.02				172,305				25.04				262,980				42.15
Exercised			-				-				-				-				(40,459	)			31.95
Forfeited			(135,098	)			27.76				(41,126	)			58.89				(55,234	)			68.11
Expired			(198,192	)			56.86				(35,295	)			68.58				(34,690	)			58.92
Outstanding, end of period			1,122,700				45.86				1,132,632				54.61				1,036,748				59.97
Options exercisable, end of period			602,505			$	58.58				731,945			$	61.05				520,679			$	62.74

		Year Ended December 31, 2024								Year Ended December 31, 2023								Year Ended December 31, 2022
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			16,333,233			$	1.28				15,975,528			$	1.27				-			$	-
Granted			1,415,000				1.75				865,000				1.37				15,975,528				1.27
Exercised			(33,750	)			1.27				-				-				-				-
Forfeited			(1,430,832	)			1.28				(451,708	)			1.27				-				-
Expired			(395,654	)			1.27				(55,587	)			1.27				-				-
Outstanding, end of period			15,887,997				1.28				16,333,233				1.28				15,975,528				1.27
Options exercisable, end of period			11,009,285			$	1.27				7,752,114			$	1.27				15,975,528			$	1.27

		Year Ended December 31, 2024								Year Ended December 31, 2023								Year Ended December 31, 2022
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			7,504,269			$	6.00				-			$	-				N/A				N/A
Granted			123,000				6.00				8,044,000				6.00				N/A				N/A
Exercised			-				-				-				-				N/A				N/A
Forfeited			(1,382,845	)			6.00				(438,381	)			6.00				N/A				N/A
Expired			(284,764	)			6.00				(101,350	)			6.00				N/A				N/A
Outstanding, end of period			5,959,660				6.00				7,504,269				6.00				N/A				N/A
Options exercisable, end of period			4,462,430			$	6.00				3,156,281			$	6.00				N/A				N/A

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$16.47 - $19.93			57,500			$	19.63				5.1			$	72				31,250			$	19.38				3.9			$	47
$20.25 - $28.37			385,617				22.84				6.2				46				30,843				25.87				5.6				-
$30.70 - $30.74			8,750				30.72				2.9				-				2,500				30.74				4.9				-
$40.04 - $48.00			171,790				42.32				4.2				-				91,677				42.65				4.4				-
$51.82 - $59.98			55,650				56.33				1.1				-				55,650				56.33				1.1				-
$60.01 - $68.41			240,406				62.09				1.5				-				238,698				62.10				1.5				-
$70.13 - $79.51			187,425				78.37				2.9				-				139,513				78.40				2.9				-
$80.61 - $82.07			15,562				81.23				2.3				-				12,374				81.27				2.1				-
			1,122,700			$	45.86				4.0			$	118				602,505			$	58.58				2.6			$	47

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $1.78			15,887,997			$	1.32				4.8			$	7,347				11,009,285			$	1.27				4.9			$	5,588
			15,887,997			$	1.32				4.8			$	7,347				11,009,285			$	1.27				4.9			$	5,588

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $6.00			5,959,660			$	6.00				5.2			$	-				4,462,430			$	6.00				5.3			$	-
			5,959,660			$	6.00				5.2			$	-				4,462,430			$	6.00				5.3			$	-

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Year Ended December 31,
		2024				2023				2022
Network, other costs		$	395			$	399			$	399
Sales and marketing			962				1,423				1,498
Technical operations and development			601				634				545
General and administrative			3,235				3,577				3,337
		$	5,193			$	6,033			$	5,779

		Year Ended December 31,
		2024				2023				2022
Network, other costs		$	104			$	131			$	104
Sales and marketing			950				931				508
Technical operations and development			261				259				407
General and administrative			325				434				801
		$	1,640			$	1,755			$	1,820

		Year Ended December 31,
		2024				2023				2022
Network, other costs		$	34			$	45			$	-
Sales and marketing			71				139				-
Technical operations and development			-				6				-
General and administrative			83				156				-
		$	188			$	346			$	-

		Year Ended December 31,
		2024				2023				2022
Company options		$	5,288			$	6,060			$	5,779
Wavelo options			1,858				2,065				1,820
Ting options			188				346				-
Capitalized stock-based compensation			(313	)			(337	)			-
Total Stock Based-Compensation expense		$	7,021			$	8,134			$	7,599

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration